No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Shaily Engineering Plastics Limited, an Indian company headquartered in Vadodara and established in 1980, specializes in the manufacturing and sale of high-precision injection-molded plastic components. The company's diverse product portfolio serves various industries: Pharmaceutical Sector: Providing essential items such as plastic pumps, spray mechanisms, insulin pens, specialized packaging, and containers for both solid and liquid medicinal formulations. Consumer Goods & Household: Manufacturing kitchenware, cooking devices, storage solutions, cleaning products, and a range of plastic (including plastic/electronic) toys. Cosmetics Industry: Producing casings for cosmetic products. Industrial Applications: Supplying automotive components and advanced engineering plastics. Shaily Engineering Plastics Limited boasts a global reach, exporting its products to approximately 35 countries worldwide.
www.shaily.comNo one on the platform currently holds SHAILY.NS.
No tracked institution reports a position in SHAILY.NS as of their last filing.
No one on the platform has traded SHAILY.NS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 20.3% | 21.6% | 21.5% | — | — | — |
| Rev. Growth % | 25.9% | 22.4% | ||||
| Profit Margin % | 17.2% | 10.0% | 8.3% | |||
| Free Cash Flow Margin % | 3.2% | -1.2% | -2.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $12.7B | +25.1% | $53.51 | $50.22–$56.87 | — | 6 |
| 2028 | $16.4B | +28.9% | $80.80 | $72.50–$87.32 | — | 6 |
| 2029 | $26.4B | +61.2% | $144.81 | $130.44–$156.02 | — | 3 |
| 2030 | $28.1B | +6.2% | $120.30 | $108.36–$129.62 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-08 | $11.00 | $10.44 | -5.1% |
| 2026-05-19 | $11.95 | $8.70 | -27.2% |
| 2026-02-12 | $11.68 | $8.10 | -30.7% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| SHAILY.NSShaily Engineering Plastics Limited | $3126.20 | -1.75% | $143.8B | — |
| JLHL.BOJupiter Life Line Hospitals Limited | $275.40 | -1.27% | $91.9B | — |
| JLHL.NSJupiter Life Line Hospitals Limited | $279.00 | +1.25% | $91.5B | — |
| MEDPLUS.BOMedPlus Health Services Limited | $655.25 | -0.81% | $78.7B | — |
| MEDPLUS.NSMedPlus Health Services Limited |
| $656.55 |
| +0.04% |
| $78.9B |
| — |
| METROPOLIS.BOMetropolis Healthcare Limited | $572.30 | -2.25% | $119.1B | — |
| METROPOLIS.NSMetropolis Healthcare Limited | $579.75 | +1.27% | $120.2B | — |
Source: Financial Modeling Prep · peers by sector/industry